Abbott Laboratories (ABT.N)
ABT.N on New York Stock Exchange
75.93USD
5:39pm BST
75.93USD
5:39pm BST
Change (% chg)
$1.42 (+1.91%)
$1.42 (+1.91%)
Prev Close
$74.51
$74.51
Open
$74.55
$74.55
Day's High
$76.38
$76.38
Day's Low
$74.50
$74.50
Volume
675,603
675,603
Avg. Vol
1,851,025
1,851,025
52-wk High
$80.67
$80.67
52-wk Low
$56.81
$56.81
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.80 | December | 23 Apr 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 9 | 9 | 9 | 9 |
| (2) OUTPERFORM | 8 | 9 | 9 | 9 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.80 | 1.81 | 1.81 | 1.81 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 18 | 7,991.69 | 8,028.00 | 7,926.00 | 8,196.51 |
| Quarter Ending Sep-19 | 18 | 8,092.77 | 8,210.00 | 7,998.00 | 8,260.64 |
| Year Ending Dec-19 | 20 | 31,983.40 | 32,485.00 | 31,705.00 | 32,940.70 |
| Year Ending Dec-20 | 20 | 34,187.20 | 35,078.00 | 33,783.00 | 34,963.80 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 20 | 0.80 | 0.81 | 0.78 | 0.80 |
| Quarter Ending Sep-19 | 20 | 0.85 | 0.90 | 0.83 | 0.84 |
| Year Ending Dec-19 | 22 | 3.22 | 3.26 | 3.17 | 3.22 |
| Year Ending Dec-20 | 22 | 3.61 | 3.68 | 3.48 | 3.60 |
| LT Growth Rate (%) | 5 | 11.60 | 12.50 | 10.80 | 11.84 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-19 | 7,473.78 | 7,535.00 | 61.22 | 0.82 |
| Quarter Ending Dec-18 | 7,816.24 | 7,765.00 | 51.24 | 0.66 |
| Quarter Ending Sep-18 | 7,650.64 | 7,656.00 | 5.36 | 0.07 |
| Quarter Ending Jun-18 | 7,711.53 | 7,767.00 | 55.47 | 0.72 |
| Quarter Ending Mar-18 | 7,285.94 | 7,390.00 | 104.06 | 1.43 |
| Earnings (per share) | ||||
| Quarter Ending Mar-19 | 0.61 | 0.63 | 0.02 | 2.82 |
| Quarter Ending Dec-18 | 0.81 | 0.81 | 0.00 | 0.01 |
| Quarter Ending Sep-18 | 0.75 | 0.75 | 0.00 | 0.58 |
| Quarter Ending Jun-18 | 0.71 | 0.73 | 0.02 | 2.86 |
| Quarter Ending Mar-18 | 0.58 | 0.59 | 0.01 | 1.71 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 7,991.69 | 7,947.22 | 7,950.43 | 7,947.60 | 8,196.51 |
| Quarter Ending Sep-19 | 8,092.77 | 8,080.73 | 8,084.87 | 8,092.26 | 8,260.64 |
| Year Ending Dec-19 | 31,983.40 | 31,851.40 | 31,832.30 | 31,842.60 | 32,940.70 |
| Year Ending Dec-20 | 34,187.20 | 34,034.30 | 34,039.80 | 34,046.00 | 34,963.80 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| Quarter Ending Sep-19 | 0.85 | 0.85 | 0.85 | 0.85 | 0.84 |
| Year Ending Dec-19 | 3.22 | 3.21 | 3.21 | 3.21 | 3.22 |
| Year Ending Dec-20 | 3.61 | 3.60 | 3.60 | 3.60 | 3.60 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-19 | 14 | 3 | 14 | 3 |
| Quarter Ending Sep-19 | 9 | 8 | 9 | 8 |
| Year Ending Dec-19 | 18 | 1 | 17 | 1 |
| Year Ending Dec-20 | 17 | 2 | 16 | 2 |
| Earnings | ||||
| Quarter Ending Jun-19 | 2 | 8 | 3 | 8 |
| Quarter Ending Sep-19 | 4 | 5 | 5 | 5 |
| Year Ending Dec-19 | 13 | 1 | 14 | 1 |
| Year Ending Dec-20 | 10 | 1 | 10 | 1 |
Earnings vs. 
Estimates- Financials stocks boost Australia benchmark; NZ inches down
- RPT-US STOCKS-Wall Street slips, weighed down by healthcare plunge
- CORRECTED-US STOCKS-Wall St dips as healthcare slide offsets chip boost
- US STOCKS-Wall Street slips, weighed down by healthcare plunge
- Abbott Labs quarterly beat overshadowed by unchanged forecast